Author

E. McClymont

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Long-term immunogenicity and efficacy of the quadrivalent human papillomavirus vaccine in women with HIV: a longitudinal cohort study.

BACKGROUND Understanding the impact of the human papillomavirus (HPV) vaccine in women with HIV, who have higher rates of HPV infection and associated disease, is vital to achieving cervical cancer elimination. We aimed to assess the immunogenicity and efficacy of the quadrivalent HPV (qHPV) vaccine up to 9 years in a...

E. McClymont, S. Blitz, Sofia Nicolls et al. · The Lancet HIV · 0 citations

Sep 2026

Rationale and design of a clinical trial of a reduced dosing schedule for the nonavalent human papillomavirus vaccine in women living with HIV: The NOVA-HIV study.

Virtually all cases of cervical cancer are caused by human papillomavirus (HPV). Women and people with a cervix living with HIV (women with HIV) are disproportionately impacted by cervical cancer; they experience higher rates of HPV infection and increased susceptibility to persistent HPV infection than women without H...

Emma Karlsen, Jenna Langlois, I. Boucoiran et al. · Contemporary Clinical Trials · 0 citations

Review Open access Sep 2026

Self-reported reactogenicity after COVID-19 vaccination with and without influenza vaccine coadministration during pregnancy in Canada.

COVID-19 vaccination in pregnancy, with or without influenza vaccine coadministration, was safe and well-tolerated by survey respondents and no new or worsening health problems were reported after coadministration of COVID-19 and influenza vaccines during pregnancy.

Sophie Tran, E. McClymont, S. Blitz et al. · Vaccine · 0 citations